Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 3474  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  » Next article
  » Previous article 
  » Table of Contents
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (115 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  


  In this Article
 »  Abstract
 »  Introduction
 »  Case report
 »  Discussion
 »  References

 Article Access Statistics
    Viewed12775    
    Printed207    
    Emailed12    
    PDF Downloaded252    
    Comments [Add]    
    Cited by others 9    

Recommend this journal

   
Year : 2002  |  Volume : 50  |  Issue : 4  |  Page : 476-9

Endolymphatic sac tumor : a rare cerebellopontine angle tumor.


Department of Neurological Sciences, Christian Medical College and Hospital, Vellore - 632004, India.

Correspondence Address:
Department of Neurological Sciences, Christian Medical College and Hospital, Vellore - 632004, India.

  »  Abstract

Endolymphatic sac tumors (ELST) are rare papillary tumors of the temporal bone. Previously named as aggressive papillary middle ear tumors, they have recently been shown to arise from the endolymphatic sac. They are a rare in cerebello-pontine angle (CPA). We present a case of an ELST who presented as a CPA tumor with hydrocephalus. He underwent a ventriculo-peritoneal shunt initially. On exploration of the CP angle, the tumor was found to be extremely vascular. He was re-explored following embolization, and a subtotal excision of the tumor was done. Extensive petrous bone infiltration and vascularity of the tumor makes total excision almost impossible with high risk of cranial nerve deficits, excessive blood loss and CSF leak. This tumor should be considered in the differential diagnosis of vascular CPA tumors which erode the petrous temporal bone. The relevant literature is reviewed.

How to cite this article:
Joseph B V, Chacko G, Raghuram L, Rajshekhar V. Endolymphatic sac tumor : a rare cerebellopontine angle tumor. Neurol India 2002;50:476


How to cite this URL:
Joseph B V, Chacko G, Raghuram L, Rajshekhar V. Endolymphatic sac tumor : a rare cerebellopontine angle tumor. Neurol India [serial online] 2002 [cited 2019 Jun 26];50:476. Available from: http://www.neurologyindia.com/text.asp?2002/50/4/476/1334




   »   Introduction Top

Endolymphatic sac tumors (ELST) are rare tumors of the temporal bone and were previously known as aggressive papillary middle ear tumors (APMET).[1] Around 60 cases have been reported in the English literature, many of them with intracranial extension.[1],[2],[3],[4],[5],[6] They are slow growing and locally invasive low grade adenocarcinomas, with a papillary cystic architecture. Following surgery they can recur locally but do not metastasize.[4] These tumors form a rare differential diagnosis for a CPA lesion .


   »   Case report Top

A 30 year old male presented with headache and vomiting for 6 months, right facial weakness for 5 months, and reduced hearing in right ear for 4 months. He also noticed gait and truncal ataxia one month before presentation. On examination, there was bilateral papilledema and bilateral horizontal gaze evoked jerky nystagmus. The right corneal reflex was diminished. There was right lower motor neurone type of facial paresis and right sensorineural hearing loss. Other cranial nerves were normal on examination. There was mild spasticity of right upper and lower limbs with soft pyramidal signs. The right plantar response was extensor. He had right cerebellar signs and truncal ataxia, and was unable to stand without support. Audiogram showed profound mixed type of hearing loss in the right ear, with normal hearing in the left ear. CT brain showed a lytic lesion with moth eaten appearance involving the mastoid air cells and extra labyrinthine bones of the right temporal bone [Figure 1a]. A partly enhancing component of the tumor measuring 6.5 x 4.5 cms was seen extending into the CPA region [Figure 1b]. The lesion had caused rotation of the brainstem and compression of the fourth ventricle with hydrocephahis. A left ventriculoperitoneal shunt was done with resolution of headache and vomiting and improvement of gait ataxia. Based on clinical and radiological grounds, the possibility of a CPA meningioma was considered and the patient underwent a right retromastoid suboccipital craniectomy. Intraoperatively there were large arterialized bleeders from the lateral aspect of the wound including the muscles and the bone. A lobulated, reddish, compressible mass was seen in the CP angle. On aspiration, a small quantity of xanthochromic fluid and altered blood was seen. Arterial bleeding occurred from 2 needle hole sites, which was controlled with difficulty. There was good tumor brain interface. As the tumor was found to be extremely vascular, surgery was abandoned and it was decided to repeat surgery after embolization of the tumor. A digital subtraction angiogram was done which showed a vascular tumor with tumor blush, fed by the ascending pharyngeal, posterior auricular and occipital branches of the right external carotid artery [Figure 2a]. Embolization was performed with poly vinyl alchohol particles (ContourTM) of 150-250 microns and 250-350 micron size with selective catheterization of the tumoral vessels. Post embolization angiogram showed complete obliteration of the tumor blush [Figure 2b]. There was no complication of embolization. He underwent a repeat surgery 2 days later, there was a 4.5 cm size tumor arising from the petrous bone. It had cystic areas with xanthochromic fluid. The cyst wall was thick with large blood vessels that were not bleeding presumably on account of the embolization. The tumor was easily separated from the brainstem, 8th, 9th and 10th cranial nerves. The part of the tumor infiltrating the petrous was solid and vascular, and was incompletely excised. In the postoperative period he was treated with antibiotics for meningitis. There were no new neurological deficits. Postoperative CT scan showed residual tumor along the petrous. A high resolution CT scan of the temporal bone was also done with 1mm contiguous slices obtained with a GE CT sytec 4000 scanner. This demonstrated the lytic nature of the tumor in the petrous bone with a moth eaten appearance. Histopathological examination [Figure - 3] showed a papillary tumor with fibrovascular core, covered by a single layer of cuboidal to low columnar epithelium. There was no evidence of mitotic activity. Colloid like material was seen covering the epithelium in some areas. Fragments of infarcted tissue were also present. He was discharged with the advice to undergo radiation therapy.


   »   Discussion Top

For many years, confusion reigned regarding the origin and terminology of adenomatous tumors of the middle ear and mastoid.[7] More recently, two distinct clinico-pathological entities have emerged -middle ear adenomatous tumors of nonpapillary mixed histologic pattern (solid, trabecular and acinar) and adenocarcinomas of papillary histologic pattern.[2] Gaffey et al[2] in 1988, coined the term APMET for a group of locally invasive and aggressive papillary tumors, frequently with intracranial extension, and presumably of middle ear origin. Prior to this in 1984, Hassard et al[3] reported the first case of an endolymphatic sac tumor when they found a small papillary adenoma of the endolymphatic sac serendipitously during decompressive surgery for Meniere's disease. This was initially reported as choroid plexus papilloma, but preoperatively the tumor was entirely extradural and there was no tumor in the posterior fossa.
Heffner[4] in 1989 reviewed 20 cases of papillary temporal bone tumors and concluded that they were low grade adenocarcinomas (as opposed to adenoma), even though the tumor cells looked bland on histology. This was because they were locally invasive and tended to recur when inadequately excised. He postulated that their true site of origin was the endolymphatic sac, as based on radiology the centers of these tumors appeared to be at or near the posteriormedial face of the petrous bone. In addition, there were histological similarities between normal endolymphatic sac and these tumors. Li et al in 1993[1] reclassified such tumors as ELST.
So far about 60 cases of ELST have been reported in the literature,[1],[2],[3],[4],[5],[6],[7],[8],[9],[10],[11],[12],[13],[14],[15],[16],[17],[18],[19],[20] but this may be an underestimation, as ELSTs have been misdiagnosed as a variety of other tumors.[4] They form a rare differential for a CPA tumor and in one series there was 1 ELST for every 300 vestibular schwanommas.[17] Though most cases of ELST are sporadic, it has been described in association with von Hippel-Lindau disease (VHL),[6] supported by genetic studies. They should be considered among other tumors associated with VHL.[10],[20] Of the cases reported in literature, only 4 reports have information on 6 or more cases.[1],[2],[4],[13]
ELST appears to be a disease of middle age with average age varying from 41 to 51 years. Some studies report a female predominance.[1],[2] Average duration of symptoms varies from 9.3 to 10.6 years.[4],[13] Unilateral hearing loss is the most common symptom, and can often be of sudden onset.[13] The other common symptoms are tinnitus and vertigo. Among the cranial nerves, 7th nerve is involved most often, followed by 9th, 10th and 5th cranial nerves. Many cases have a bluish-red discolouration seen through an intact tympanic membrane, or a vascular mass protrude through it into the external auditory canal.[1],[2],[4],[5] In our patient, hearing loss was present for a short duration of 4 months, which is unusual, considering the size of the tumor and temporal bone destruction. It is more likely that he became aware of the hearing loss recently. The presentation with raised ICP and hydrocephalus is also unusual. Only one patient in the 4 larger series forming a total of 44 cases had hydrocephalus, and that to at one year follow up[13] after treatment. In our case, the patient bad a mass in the external auditory canal for which a biopsy was done and found to be very vascular. Though the biopsy was inconclusive, we feel that it represents tumor infiltration.
A number of destructive tumors of the temporal bone can resemble ELST.[1],[9],[11],[17] The most common tumor confused with ELST is the paraganglioma.[2] Other tumors include CPA choroid plexus papilloma, papillary meningiomas, ceruminous gland tumors, metastatic thyroid or renal cell carcinoma, benign adenomatous tumors, primary bone tumors and laterally placed chordomas. In our case prior to the first surgery, the clinical and radiological picture was suggestive of a meningioma. However considering the tremendous vascularity of the lesion during surgery and the angiography picture postoperatively, the possibility of a paraganglioma was considered. Peroperative histology smear was reported as a carcinoma. Radical surgery or total excision was done in 11 of Heffner's 20 cases,[4] of which only 2 were large tumors. Radiotherapy (RT) was given to only one of these cases, and that too preoperatively. Ten of these 11 cases were free of disease on follow up. Of the 8 where subtotal/partial excision was done, there were 6 large tumors. RT was given to 5, of which 2 were disease free. From the above facts it appears that curative therapy involves adequate surgical tumor excision, which usually entails radical temporal bone surgery and has better results than subtotal or partial excision followed by RT. It has been quoted that there is a 90% cure rate for total tumor removal without radiation'.[1],[4],[5],[17] whereas radiation of known residual tumor had only 50% efficacy.[1],[4],[17] However it must be realized that this total removal/radical surgery group had a greater number of smaller tumors compared to the 'subtotal/partial' group. While curative therapy with total tumor excision is desirable, in advanced tumors, complete excision is virtually impossible[17] as the tumor can involve the lower cranial nerves, sigmoid sinus and petrous portion of the carotid artery. Preoperative embolization done in our case was very useful in reducing vascularity and has been described by other authors.[5],[14],[16]

 

  »   References Top

1.Li JC, Brackman DE, Lo WWM et al : The reclassification of aggressive adenomatous mastoid neoplasm as endolymphatic sac tumors. Laryngoscope 1993; 103: 1342-1348.   Back to cited text no. 1    
2.Gaffey MJ, Mills SE, Fechner RE et al : Aggressive papillary middle ear tumor : a clinicopathologic entity distinct from middle-ear adenoma. Am J Surg Pathol 1988; 12: 790-797.   Back to cited text no. 2    
3.Hassard AD, Boudreau SF, Cron CC : Adenoma of the endolymphatic sac. J Otolaryngology 1984; 13: 213-216.   Back to cited text no. 3    
4.Heffner DK : Low grade adenocarcinoma of probable endolymphatic sac origin : a clinicopathological study of 20 cases. Cancer 1989; 64: 2292-2302.   Back to cited text no. 4    
5.Jaap Reijneveld, Patrick Hanlo, Gisele Groenewoud et al : Endolymphatic sac tumor : a case report and review of literature. Surg Neurol 1997; 48: 368-373.   Back to cited text no. 5    
6.Poe DS, Tarlov C, Thomas CB et al : Aggressive papillary tumors of temporal bone. Otolaryngology. Head Neck Surg 1993; 108: 80-86.   Back to cited text no. 6    
7.Lo WWM, Applegate LJ, Carberry JN et al : Endolymphatic sac tumors : Radiologic appearance. Radiology 1993; 189: 199-204.   Back to cited text no. 7    
8.Feghali JG, Levin RJ, Llena J et al : Aggressive papillary tumors of the endolymphatic sac: clinical and tissue culture characteristics. Am J Otology 1995; 16: 778-782.   Back to cited text no. 8    
9.Forrest AW, Turner JJ, Fagan PA : Aggressive papillary middle ear tumor. J Laryngology Otology 1991; l05: 950-953.   Back to cited text no. 9    
10.Kawahara N, Kume H, Ueki K et al : VHL gene inactivation in an endolymphatic sac tumor associated with von Hippellindau disease. Neurology 1999; 53: 208-210.   Back to cited text no. 10    
11.Kempermann G, Neumann HPH, Volk B : Endolymphatic sac tumors. Histopathology 1998; 33: 2-10.   Back to cited text no. 11    
12.Lavoie M, Morency RM : Low grade papillary adenomatous tumors of the temporal bone : report of two cases and review of the literature. Modern Pathology 1995; 8: 603-608.   Back to cited text no. 12    
13.Megerian CA, McKenna MJ, Nuss RC et al : Endolymphatic sac tumors: histopathologic confirmation, clinical characterization and implication in von Hippel-Lindau disease. Laryngoscope 1995; 105: 801-808.   Back to cited text no. 13    
14.Mukherji SK, Castillo M : Adenocarcinoma of the endolymphatic sac : imaging features and preoperative embolisation. Neuroradiology 1996; 38: 179-180.   Back to cited text no. 14    
15.Panchwagh J, Goel A, Shenoy A : Bilateral endolymphatic sac papillary carcinoma. Br J Neurosurg 1999; 13: 79-81.   Back to cited text no. 15    
16.Quallet JC, Marsot-Dupuch K, Effenterre RV et al : Papillary adenoma of endolymphatic sac origin: a temporal bone tumor in von Hippel-Lindau disease. J Neurosurg 1997; 87: 445-449.   Back to cited text no. 16    
17.Roche PH, Dufour H, Figarella-Branger P et al : Endolymphatic sac tumors : report of three cases. Neurosurgery 1998; 42: 927-932.   Back to cited text no. 17    
18.Roncaroli F, Giangaspero F, Piana S et al : Low grade adenocarcinoma of endolymphatic sac mimicking jugular paraganglioma at clinical and neuroradiological examination. Clin Neuropathol 1997; 16: 243-246.   Back to cited text no. 18    
19.Stendel R, Suess O, Prosene N et al : Neoplasm of endolymphatic sac origin: clinical, radiological and pathological features. Acta Neurochirurgica (Wien) 1998; 140: 1083-1087.   Back to cited text no. 19    
20.Tibbs RE, Bowles AP, Raila FA et al : Should endolymphatic sac tumors be considered a part of the von Hippel-Lindau complex? Pathology case report. Neurosurgery 1997; 40: 848-855.   Back to cited text no. 20    

 

Top
Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow